Home » Newsletters » BioWorld Science

BioWorld Science

July 4, 2002

View Archived Issues

BI-K0376 effective against multiresistant acne-associated bacteria

Phase III trials in preparation for Cotara in advanced brain cancer

Alfimeprase enters phase I for peripheral arterial occlusion

Avant receives SBIR grant for anthrax vaccine delivery vectors

deCODE and Elitra antibiotic drug discovery alliance advances

Clinical trials confirm that eplerenone is safe and effective in Rx of hypertension

New data on the use of omapatrilat in hypertension and chronic heart failure

Melanoma vaccine candidate based on bacterial adjuvant protein and MART-1-derived peptide

Behavioral effects of SSR-149415 in animal models of anxiety and depression

Neurochemical effects of new 5-HT6 antagonist in rat medial prefrontal cortex

Cognition-enhancing effects of sunifiram demonstrated in rodent models

Antiaggressive effects of MKC-242 mediated via inhibition of 5-HT2A receptor function

PK/PD analysis of schizophrenic patients treated with blonanserin

Highly potent prodrug for use in ADEPT of cancer

Researchers at Pfizer design a mutual prodrug of atorvastatin and amlodipine

New antibacterial carbapenems presented by Sumitomo

Taisho designs cyanopyrrolidine DPP-IV inhibitors

Yamanouchi and Rational Drug Design claim antiherpes drugs

Novel inhibitors of MMPs and ADAMs in the Pfizer pipeline

Synthesis of sst2 agonists and their use in diabetes and other conditions

Takeda patent discloses novel factor Xa inhibitors

Advexin lung cancer patient reaches five-year survival

Positive phase II results announced for indiplon-MR in elderly insomnia patients

Phase II trials of FluINsure and StreptAvax begin enrollment

Indevus licenses worldwide rights to CT-3 from Atlantic Technology Ventures

Acamprosate deemed nonapprovable in U.S.

T-1249 shows anti-HIV activity in phase I/II trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...